Company Overview
- Headquarters
- 1633 Broadway 22nd Floor Suite C, New York NY
- Website
- delcath.com
- Phone
- (212) 489-****
- Employees
- 88
- Founded in
- 1987
- Industry
- Materials/Manufacturing
- Stock Symbol
- OTCQB:DCTH
- NAICS Code
- 33, 339, 3254, 32, 325, 32541
- SIC Code
- 28, 384, 38, 283
Financials & Stats
Revenue
$3B
Who is Delcath Systems Inc
Delcath Systems Inc. is a specialty pharmaceutical and medical device company based in New York, New York. The company employs 88 people and generates $2.7 million in annual revenue. Delcath focuses on the development and commercialization of treatments for primary and metastatic liver cancers. Their flagship product is Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS), a system designed to deliver high-dose chemotherapy directly to the liver while minimizing systemic exposure. This system is marketed as the Delcath Hepatic CHEMOSAT® Delivery System for Melphalan (CHEMOSAT) in Europe. Delcath's Melphalan/HDS has received CE Mark approval and has been used in over 250 treatments at more than 20 leading European cancer centers. The company is currently conducting clinical trials for the treatment of hepatic dominant ocular melanoma, hepatocellular carcinoma, and intrahepatic cholangiocarcinoma. For more information about Delcath Systems Inc. and its products, visit their website at delcath.com.
Company Leadership
Delcath Systems Inc Industry Tags
Delcath Systems Inc Tech Stack
Companies Similar to Delcath Systems Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Delcath Systems Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | San Diego, CA | 2010 | |
| 3M | 24 | Palatine, IL | 1953 | |
| 3M | 9 | Orem, UT | 1993 | |
| 3M | ||||
| 3M | 25 | 2016 |